⌘K (Command K) to search

Sign in Sign up free

10-QAccepted May 14, 4:08 PM ET

IGENE BIOTECHNOLOGY INC 10-Q

IGENE BIOTECHNOLOGY INC

sec.gov View full filing

Accepted (ET)

4:08 PM

May 14, 2010

Filed

May 14, 2010

Documents

6

Size

234.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.

Filing details

Company: IGENE BIOTECHNOLOGY INC
CIK: 0000793160
Form: 10-Q
Accepted: May 14, 4:08 PM ET
Filed: May 14, 2010
Size: 234.6 KB
Accession: 0000793160-10-000004

Documents · 6

final03312010main.txtPrimary
QUARTERLY REPORT FOR PERIOD ENDED MARCH 31 2010 W/O EXHIBITS
ex311.txt
RULE 13A-14(A) OR 15D-14(A) CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER
ex312.txt
RULE 13A-14(A) OR 15D-14(A) CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIAL OFFICER
ex321.txt
RULE 13A-14(B) OR 15D-14(B) CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO RULE 906 OF THE SARBANES-OXLEY ACT OF 2002.
ex322.txt
RULE 13A-14(B) OR 15D-14(B) CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO RULE 906 OF THE SARBANES-OXLEY ACT OF 2002.
final03312010q.pdfPrimary
QUARTERLY REPORT FOR PERIOD ENDED MARCH 31 2010 - COMPLETE, INCLUDING EXHIBITS